173
Views
29
CrossRef citations to date
0
Altmetric
Original Research

Melatonin receptor stimulation by agomelatine prevents Aβ-induced tau phosphorylation and oxidative damage in PC12 cells

, &
Pages 387-396 | Published online: 21 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Fang Cheng, Huanxian Chang, Fengfeng Yan, Aixing Yang, Jing Liu & Yuliang Liu. (2020) Agomelatine Attenuates Isoflurane-Induced Inflammation and Damage in Brain Endothelial Cells. Drug Design, Development and Therapy 14, pages 5589-5598.
Read now

Articles from other publishers (28)

Russel J. Reiter, Ramaswamy Sharma, Maira Smaniotto Cucielo, Dun Xian Tan, Sergio Rosales-Corral, Giuseppe Gancitano & Luiz Gustavo de Almeida Chuffa. (2023) Brain washing and neural health: role of age, sleep, and the cerebrospinal fluid melatonin rhythm. Cellular and Molecular Life Sciences 80:4.
Crossref
Emily Knight, Thangiah Geetha, Tom L. Broderick & Jeganathan Ramesh Babu. (2023) The Role of Dietary Antioxidants and Their Potential Mechanisms in Alzheimer’s Disease Treatment. Metabolites 13:3, pages 438.
Crossref
Qiang Su, Tian Li, Guo-Wei Liu, Yan-Li Zhang, Jun-Hong Guo, Zhao-Jun Wang, Mei-Na Wu & Jin-Shun Qi. (2023) Agomelatine: a potential novel approach for the treatment of memory disorder in neurodegenerative disease. Neural Regeneration Research 18:4, pages 727.
Crossref
Sun Xiao-Lei, Xia Tian-Shuang, Jiang Yi-Ping, Wang Na-Ni, Xu Ling-Chuan, Han Ting & Xin Hai-Liang. (2022) Humulus lupulus L. extract and its active constituent xanthohumol attenuate oxidative stress and nerve injury induced by iron overload via activating AKT/GSK3β and Nrf2/NQO1 pathways. Journal of Natural Medicines 77:1, pages 12-27.
Crossref
Tian Lan, Yuhan Wu, Yulei Zhang, Shuhan Li, Zhanpeng Zhu, Liyan Wang, Xueqin Mao, Ye Li, Cuiqin Fan, Wenjing Wang & Shu Yan Yu. (2022) Agomelatine rescues lipopolysaccharide-induced neural injury and depression-like behaviors via suppression of the Gαi-2-PKA-ASK1 signaling pathway. Journal of Neuroinflammation 19:1.
Crossref
Meihao Liang, Lili Gu, Hongjie Zhang, Jingli Min, Zunyuan Wang, Zhen Ma, Chixiao Zhang, Shenxin Zeng, Youlu Pan, Dongmei Yan, Zhengrong Shen & Wenhai Huang. (2022) Design, Synthesis, and Bioactivity of Novel Bifunctional Small Molecules for Alzheimer’s disease. ACS Omega 7:30, pages 26308-26315.
Crossref
Tian Li, Qiang Su, Zhina Zhang, Yanli Zhang, Mingxuan Yang, Zhuoran Wang, Junhong Guo, Zhaojun Wang, Meina Wu, Hongyan Cai & Jinshun Qi. (2022) Ube2c-inhibition alleviated amyloid pathology and memory deficits in APP/PS1 mice model of AD. Progress in Neurobiology 215, pages 102298.
Crossref
Jaydeep Roy, Kan Yin Wong, Luca Aquili, Md. Sahab Uddin, Boon Chin Heng, George Lim Tipoe, Kah Hui Wong, Man Lung Fung & Lee Wei Lim. (2022) Role of melatonin in Alzheimer’s disease: From preclinical studies to novel melatonin-based therapies. Frontiers in Neuroendocrinology 65, pages 100986.
Crossref
Yuqing Tang, Dongju Zhao, Fan Yang, Gaoju Pang, Zuhao Sun, Jin Chang & Yan Dou. (2022) Hsp90 co-chaperone degradation combined with antioxidation nanostrategy to rescue tauopathy-induced Alzheimer’s disease. Chemical Engineering Journal 432, pages 134352.
Crossref
Xinrong Pei, Fangyan Hu, Feiya Luo, Xianglu Huang, Xiaoling Li, Shuxia Xing & Dingxin Long. (2021) The neuroprotective effects of alpha‐lipoic acid on an experimental model of Alzheimer's disease in PC12 cells. Journal of Applied Toxicology 42:2, pages 285-294.
Crossref
Xiao-bo Yang, Heng-bing Zu, Yong-fei Zhao & Kai Yao. (2022) Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice. Frontiers in Aging Neuroscience 13.
Crossref
Andrila E. Collins, Tarek M. Saleh & Bettina E. Kalisch. (2022) Naturally Occurring Antioxidant Therapy in Alzheimer’s Disease. Antioxidants 11:2, pages 213.
Crossref
Teera Chanmanee, Jittiporn Wongpun, Chainarong Tocharus, Piyarat Govitrapong & Jiraporn Tocharus. (2022) The effects of agomelatine on endoplasmic reticulum stress related to mitochondrial dysfunction in hippocampus of aging rat model. Chemico-Biological Interactions 351, pages 109703.
Crossref
Doris Loh & Russel J. Reiter. (2021) Melatonin: Regulation of Biomolecular Condensates in Neurodegenerative Disorders. Antioxidants 10:9, pages 1483.
Crossref
Shichao Guo, Jinyu Yang, Jianpeng Qin, Izhar Hyder Qazi, Bo Pan, Shengqin Zang, Tianyi Lv, Shoulong Deng, Yi Fang & Guangbin Zhou. (2021) Melatonin Promotes In Vitro Maturation of Vitrified-Warmed Mouse Germinal Vesicle Oocytes, Potentially by Reducing Oxidative Stress through the Nrf2 Pathway. Animals 11:8, pages 2324.
Crossref
Jaydeep Roy, Ka Chun Tsui, Jonah Ng, Man-Lung Fung & Lee Wei Lim. (2021) Regulation of Melatonin and Neurotransmission in Alzheimer’s Disease. International Journal of Molecular Sciences 22:13, pages 6841.
Crossref
Yiqiang Cao, Fei Wang, Yonggang Wang & Jiang Long. (2021) Agomelatine prevents macrophage infiltration and brain endothelial cell damage in a stroke mouse model. Aging 13:10, pages 13548-13559.
Crossref
Benita Wiatrak & Katarzyna Balon. (2020) Protective Activity of Aβ on Cell Cultures (PC12 and THP-1 after Differentiation) Preincubated with Lipopolysaccharide (LPS). Molecular Neurobiology 58:4, pages 1453-1464.
Crossref
Hui-Hua Li, Xiao-Yan Yao, Sheng Tao, Xue Sun, Pan-pan Li, Xi-xin Li, Zhu-Li Liu & Chao Ren. (2021) Serotonin 2 Receptors, Agomelatine, and Behavioral and Psychological Symptoms of Dementia in Alzheimer’s Disease. Behavioural Neurology 2021, pages 1-6.
Crossref
Mengke Wang, Xing Liu, Zejie Zhang, Jiawen Yu, Jiajia Liu & Yiqiang Wu. (2020) Phytochemicals and bioactive analysis of different sweet tea ( Lithocarpus litseifolius [Hance] Chun ) varieties . Journal of Food Biochemistry 45:3.
Crossref
Fatma Nihan Cankara, Caner Günaydın, Zülfinaz Betül Çelik, Yasemin Şahin, Şakir Pekgöz, Yalçın Erzurumlu & Kanat Gülle. (2020) Agomelatine confers neuroprotection against cisplatin-induced hippocampal neurotoxicity. Metabolic Brain Disease 36:2, pages 339-349.
Crossref
Antonio Gonzalez. (2020) Antioxidants and Neuron-Astrocyte Interplay in Brain Physiology: Melatonin, a Neighbor to Rely on. Neurochemical Research 46:1, pages 34-50.
Crossref
Pawaris Wongprayoon & Piyarat Govitrapong. (2020) Melatonin Receptor as a Drug Target for Neuroprotection. Current Molecular Pharmacology 14:2, pages 150-164.
Crossref
Yaojun Ju & Kin Yip Tam. (2020) 9R, the cholinesterase and amyloid beta aggregation dual inhibitor, as a multifunctional agent to improve cognitive deficit and neuropathology in the triple-transgenic Alzheimer's disease mouse model. Neuropharmacology 181, pages 108354.
Crossref
Matias Estaras, Ana M. Marchena, Miguel Fernandez‐Bermejo, Jose M. Mateos, Daniel Vara, Vicente Roncero, Gines M. Salido & Antonio Gonzalez. (2020) The melatonin receptor antagonist luzindole induces the activation of cellular stress responses and decreases viability of rat pancreatic stellate cells. Journal of Applied Toxicology 40:11, pages 1554-1565.
Crossref
Ruisan Zhang, Jing Luan, Fengrui Hu, Jiaming Lv, Jieyuan Zhang, Kang Li, Huifang Guo, Jianghong Cheng, Peng Chen, Yuelin Zhang, Qiang Cai & Xingchun Gou. (2020) Effect of (m)RVD-hemopressin against Aβ1-42-induced apoptosis and inhibition of neurite outgrowth in SH-SY5Y cells. Neuropeptides 81, pages 102044.
Crossref
Ruisan Zhang, Yongcai Zheng, Fengrui Hu, Xin Meng, Bosen Lv, Kejing Lao, Xingchun Gao, Xiaohua Zhang & Xingchun Gou. (2020) Effect of (m)VD-hemopressin against Aβ1-42-induced oxidative stress and apoptosis in mouse hippocampal neurons. Peptides 124, pages 170185.
Crossref
Fengjun Cao, Zhongjie Liu & Guanjun Sun. (2020) Diagnostic value of miR-193a-3p in Alzheimer's disease and miR-193a-3p attenuates amyloid-β induced neurotoxicity by targeting PTEN. Experimental Gerontology 130, pages 110814.
Crossref